NextCure, Inc. (NXTC) |
| 6.3 0.02 (0.32%) 10-14 12:07 |
| Open: | 6.505 |
| High: | 6.505 |
| Low: | 6.11 |
| Volume: | 10,034 |
| Market Cap: | 23(M) |
| PE Ratio: | -0.72 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 8.17 |
| Resistance 1: | 6.82 |
| Pivot price: | 5.71 |
| Support 1: | 4.64 |
| Support 2: | 3.86 |
| 52w High: | 15.74 |
| 52w Low: | 1.55 |
Financials
| EPS | -8.710 |
| Book Value | 2.990 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -69.0 |
| Return on Equity (ttm) | -204.6 |
Company news
Fri, 09 Oct 2026
NextCure Inc (NASDAQ: NXTC) Stock Price, News & Analysis - Kalkine
Fri, 02 Oct 2026
Nextcure Stock Price Forecast. Should You Buy NXTC? - StockInvest.us
Fri, 25 Sep 2026
About 90% of votes cast backed a share split. NextCure (NXTC) now asks a court to validate it. - Stock Titan
Mon, 10 Aug 2026
Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001 - PR Newswire
Tue, 04 Aug 2026
Adar1 Capital Management buys $1.6m in NextCure (NXTC) shares - Investing.com
Tue, 14 Jul 2026
NXTC Stock Alert: Halper Sadeh LLC is Investigating Whether NextCure, Inc. is Obtaining a Fair Price for its Shareholders - nny360.com
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
